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As the indications for total hip arthroplasty increase, the prevalence of extensive proximal femoral bone loss will increase as a
consequenceofmassiveosteolysis,stressshieldingandmultiplerevisions.Proximalfemoralbonestockdeﬁciencyprovidesamajor
challenge for revision hip arthroplasty and is likely to account for a signiﬁcant future caseload. Various surgical techniques have
been advocated included impaction allografting, distal press-ﬁt ﬁxation and massive endoprosthetic reconstruction. This review
article provides a systematic review of the current literature to assess the outcome of revision hip arthroplasty using allograft to
reconstruction massive proximal femoral bone loss.
1.Introduction
As the need for total hip arthroplasty increases, the incidence
of extensive proximal femoral bone loss will increase as a
consequence of massive osteolysis, stress shielding and mul-
tiple revisions [1–5]. Proximal femoral bone stock deﬁciency
provides a major challenge for revision hip arthroplasty and
is likely to account for a signiﬁcant future caseload [6].
Various surgical techniques have been advocated includ-
ed impaction allografting techniques [7, 8], distal press-ﬁt
ﬁxation [9, 10], and massive endoprosthetic reconstruction
[11–13]. Individual studies have reported a 58% to 84%
survivorship of massive endoprosthetic reconstruction (or
megaprostheses) with average followup ranging from 5 to 10
years [11–13] .Ar e c e n tr e t r o s p e c t i v er e v i e wo f4 0 3p r o x i m a l
femoralreplacements(endoprostheticreconstructions)from
ﬁve institutions reported a 10- and 15-year survival rate of
75%, with mechanical causes being the commonest mode of
failure [14].
A proximal femoral allograft reconstruction requires the
use of a prosthesis bridging the host-allograft junction and
obtaining ﬁxation in the distal femur. The enhancement of
future bone stock is an important advantage purported to
this method of reconstruction that has been utilized in
proximal femoral bone loss secondary to tumors and aseptic
osteolysis. Diﬀerences in the morphology of the host-
allograft junction, the use of cement, and the method of
attachment of the host abductor musculature have all been
described.
The three principal aims of this systematic review were as
follows:
(1) to document variations in the surgical techniques
used,
(2) to assess the clinical outcome of allograft prosthesis
composites (APC) for massive proximal femoral
bone loss,
(3) to quantify complication rates in relation to the
surgical technique used.
2. Methods
A comprehensive search of the MEDLINE, EMBASE, and
the National Institutes of Health online database PubMed
fromtheearliestrecordstothetimeofreview(January2011)
was performed. The following Medical Subject Headings
(MeSH)termswereused:“allograft,”“compositegraft”inthe
manuscript title, and “proximal femoral” in the manuscript
abstract. The keywords were used as both text words and
Medical Search Headings (MeSH terms).2 Advances in Orthopedics
Two authors (B. A. Rogers, A. Sternheim) independently
applied the search strategy to the diﬀerent databases and
reviewed the selected references. Titles, abstracts and papers
were reviewed independently.
The following inclusion criteria were used:
(1) studies retrieved by the database search using the
Medical Subject Headings detailed above,
(2) studies speciﬁcally reporting outcomes relating to
proximal femur composite.
The following exclusion criteria were used:
(1) non-English language,
(2) case reports,
(3) review articles,
(4) not relating to human surgery,
(5) patients with advanced oncological pathology,
(6) followup less than 2 years.
Where more than one publication existed relating to
the outcomes of same cohort of patients from the same
institution, the most recent publication only was used.
Full-textmanuscriptswereobtainedandreviewedforthe
studies identiﬁed using the above criteria. The method of
review followed the authoritative methodology described by
Mohit [15].
Allograft-prostheticcomposite(APC)isatechniqueused
torestorebonestockandmechanicalstabilitytotheproximal
femur (see Figures 1(a)–1(d),a n d2). The studies analyzed in
thisliteraturereviewconsiderasingletechnique,APC,rather
than a single diagnosis; this technique has been utilized for
oncological and nononcological surgery.
Eight studies report on APC used in non-oncological
conditions (septic or aseptic loosening) and six report on
surgeries performed for malignant or nonmalignant proxi-
malfemoralpathology.Twostudiesreportonpatientcohorts
with both indications.
The primary outcome of interest was further revision
of the femoral component and the secondary outcomes of
interest were other complications such as infection, disloca-
tion, and nonunion.
Statistical analysis was performed on the selected papers
to assess the pooled success rate. The eﬀect (proportion) was
calculated for every individual study and the pooled eﬀect
considering all the studies.
3. Results
3.1. Studies. Sixteen studies reported on outcomes of prox-
imal femoral composite allograft used to reconstruct major
bone defects (see Table 1) .A l ls t u d i e sw e r er e t r o s p e c t i v e
case series and provide level IV evidence. All studies were
published within the last ﬁfteen years. Average followup
r a n g e df r o m2t o1 6 . 2y e a r s .T h et o t a ln u m b e ro fa l l o g r a f t
reconstructions reported in all the studies was 498. The
surgical techniques, clinical outcomes and complications
were collated for all these published studies.
3.2. Surgical Techniques. The described surgical techniques
varied, as shown in Tables 2 and 3.
Four studies described the complete resection of the
proximal femur as the approach employed; however, the
transtrochanteric approach was the most common reported.
Regarding the morphology of the osteotomy used at
the junction between the proximal allograft and distal host
femur, 8 studies reported a transverse femoral osteotomy, 3
that were augmented with plate ﬁxation to enhance stability
at the allograft-host junction. The remainder of the studies
reported either a step or oblique femoral osteotomy.
The management of the proximal host femur varied. In
9 studies the proximal host femur was fully resected, with 5
studies using the split host proximal femur as an onlay graft
after the APC had been inserted. Two studies did not detail
this aspect of the surgical technique. Four studies reported
the use of cortical strut allografts to reinforce the allograft-
host junction [6, 18, 22, 29], with one study reporting use in
every case [22].
The techniques used for ﬁxation of the prosthesis to the
allograft, and for distal ﬁxation to the host femur is shown in
Table 3. There are 14 studies reporting cemented ﬁxation of
the prosthesis to the allograft; however, distal ﬁxation varied
with6uncemented,4cemented,5studiesemployedavariety
of techniques and one study did not report.
3.3. Clinical Outcomes. The primary outcome of interest was
further revision of the femoral component, and Table 4
shows the reported failure rate and success rate for the
allograft prosthesis composite in each study. The success rate
was deﬁned as the reported survivorship of the APC.
The total cohort included 498 patients with a mean
f o l l o wu po f8 . 1y e a r s( r a n g e2t o1 6 . 2y e a r s ) .T h ep o o l e d
success rate was 81% (95% CI 77%–86%).
However, the number of cases and length of followup
varied substantially between the studies. For example, Roque
et al. reported an 82% survivorship rate for 73 allograft pros-
thesis reconstructions at 6.7 years followup [23], whereas
Saﬁr et al. reported 15 year Kaplan-Meier survivorship data
on 50 patients of 82% [19].
3.4. Complications. Table 4 details the reported major com-
plications. The infection rate ranged from 0% to over 21%,
with a pooled mean of 8%. The two studies with a reported
infection rate of over 20% had only 14 and 15 patients,
respectively [13, 29]. Conversely, the four studies reporting
the lowest infection rates (0 to 4%) had a mean patient
cohort of 40 patients [6, 16, 17, 20].
Dislocation is a signiﬁcant postoperative complication,
however ﬁve out of the sixteen studies did not report the
incidence of dislocation [13, 24, 25, 27, 28]. For the eleven
studies that did report dislocation rate the mean was 12.8%
with a range 0% [16, 23] to 40% [18]. The mean reported
dislocation rate in studies that used a technique of splitting
the host proximal femur to use as an onlay graft was
9.8%, compared to 14.9% in studies that resected the entire
proximal femur.Advances in Orthopedics 3
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Figure 1: (a) Prosthesis cemented into allograft. (b) Trochanteric slide approach to hip, with lateral cortex osteotomy to facilitate removal
of in situ femoral component. (c) Allograft-prosthesis composite inserted into host, with junctional step cut. (d) Remnants of host proximal
femur are ﬁxed around allograft, especially at the allograft-host junction, and the greater trochanter reattached.
Figure 2: A radiograph 17 years after proximal femoral allograft
(reprinted from Saﬁr et al. [19]).
Failure of the APC, either resulting from aseptic loos-
ening or fracture (Table 4) ranges from 0% to 28%. The
mean reported aseptic loosening or fracture rate was 13.7%
for studies that used cement for ﬁxation into distal host
femur,comparedto9.1%forthosestudiesusinguncemented
ﬁxation in the distal host femur. However, the diﬀerence was
not statistically diﬀerent.
4. Discussion
4.1. Clinical Outcome. Severe proximal femoral bone loss
is creating an increasing caseload of complex cases for the
reconstructivehipsurgeon[6].Theuseofallograftprosthesis
composite (APC) is one surgical solution used to address
this problem and restore mechanical stability to the proximal
femur. This analysis reviews the surgical techniques, clinical
outcomes and complication, incorporating a total patient
cohort of 498 from sixteen studies with a mean follow up of
8.1 years (range 2 to 16.2 years). The pooled success rate was
81% (95% CI 77%–86%), see Table 4, and provides evidence
that this technique is valid and durable when performed by
suitable trained and experienced surgeons, in institutions
with the facilities to support such complex surgery.
4.2. Surgical Approaches and Complications. Surgical tech-
nique varied between the studies with regard to surgical
approach, storage technique of the allograft bone, ﬁxation
techniques of the prosthesis to the proximal allograft, distal
host femur and the junction between the allograft and host
bone (see Table 2).
Several diﬀerent surgical approaches were utilized in the
reportedstudies.Fourstudiesallpertaintotumourresection
used a direct lateral approach with complete resection of the
proximal femur. Trochanteric slide osteotomy was used in
two studies both reported on patients who had revision of
a failed hip arthroplasty. A transtrochanteric approach was
reported by Vastel et al. and led to a high rate of trochanteric
nonunion (25/34) with the authors recommending the use
of a trochanteric plate to avoid proximal migration of the
trochanter [20].4 Advances in Orthopedics
Table 1: Sixteen studies using allograft prosthetic composite in the treatment of proximal femoral bone loss, number of patients per study,
primary diagnosis, and mean followup.
Study n Primary diagnosis Mean followup (yrs)
1 Chandler et al. [6] 30 Aseptic 2
2 Langlais et al. [16] 21 Tumor 6
3 Haddad et al. [17] 55 Tumor, Aseptic, Septic revision 8.8
4Z e h r e t a l . [ 13]1 4 T u m o r 1 0
5 Zmolek and Dorr [18] 15 Aseptic failure 2
6S a ﬁ r e t a l . [ 19] 50 Septic, aseptic 16.2
7V a s t e l e t a l . [ 20] 44 Aseptic failure 7.1
8 Babis et al. [21]7 2 A s e p t i c 1 2
9L e e e t a l . [ 22] 15 Aseptic, septic loosening 4.2
10 Roque et al. [23] 73 Tumor 6.7
11 Biau et al. [24] 32 Tumor 5.6
12 Donati et al. [25] 22 Tumor 4.8
13 Farid et al. [26] 20 Tumor 6.3
14 Graham and Stockley [27] 25 Aseptic, septic loosening 4.5
15 Muscolo et al. [28] 37 Tumor 7.5
16 J. W. Wang and C. J. Wang [29] 15 Aseptic, septic loosening 7.6
Table 2: Surgical techniques used including approach, the type of femoral osteotomy performed at the host bone-allograft junction, and
whether the host proximal femur was resected or split and used as an onlay graft. NR: not reported. Study numbers correlate with Table 1.
Study n Surgical approach Femoral osteotomy Host proximal femur
1 30 Trochanteric slide Step cut (7) transverse (23) NR
2 21 Complete resection Step cut Resected
3 55 NR Transverse (28), step cut (12) Resected
4 14 Complete resection NR Resected
5 15 Posterolateral (9), trochanteric Slide (2) Oblique Resected
6 50 Trochanteric slide Step cut Split and onlay
7 44 Transtrochanteric Transverse Split and onlay
8 72 Hardinge (44), posterior (11), transtrochanteric (17) Step cut (62), telescoping (10) Split and onlay
9 15 Transtrochanteric Transverse (9), step cut (6) NR
10 73 Complete resection NR Resected
11 32 Trochanteric slide (12), resection (20) Transverse Resected
12 22 Complete resection Transverse Resected
13 20 NR NR Resected
14 25 Trochanteric slide Step cut Split and onlay
15 37 Posterolateral (28), transtrochanteric (10) Transverse Resected
16 15 Transtrochanteric Transverse Split and onlay
Trochanteric nonunion and abductor strength are also
inﬂuenced by surgical approach. The trochanteric slide
osteotomy aims to maintain the continuum of tissue from
the abductors and the greater trochanter to the vastus later-
alis. This approach has been reported to have a higher rate
of trochanteric union [30]. The trochanteric slide osteotomy
has been further modiﬁed to maintain the external rotators
and thus improve hip stability [30–32].
The junctional osteotomy between the host femur and
theproximalallograftwastransverse,obliqueorstep-cut(see
Table 2). A step-cut osteotomy may oﬀer more rotational
stability while an oblique osteotomy may oﬀer more surface
area for bone in-growth compared to a transverse osteotomy.
Langlais et al. reported on two cases of loosening with
junctional failure that they attributed to a lack of a step-
cut osteotomy at the junction [16]. This junction may
be further reinforced with strut allografts [6, 18, 22, 29].
Nonunion of the junction between the native femur and
the proximal allograft causes macro motion at the junction
that is treated with bone grafting, plating, and/or a strut
allograft [16]. Host-allograft junctional nonunion may be
reduced by augmentation with additional autologous bone
graft and supporting it with either a plate or a strut allograft.
Several studies highlight the bone union at the host-allograftAdvances in Orthopedics 5
Table 3: Table showing methods of implantation of prosthesis into allograft to form the allograft prosthesis composite (APC) and methods
for securing APC to distal host femur. NR: not reported. Study numbers correlate with Table 1.
Study Allograft-prosthesis ﬁxation APC-host bone ﬁxation
1 Cemented Uncemented
2 Cemented Cemented
3 Cemented Cemented
4 Cemented (16), uncemented (2) Cemented(14), Uncemented(2), + plating(2)
5 Uncemented Uncemented + plating
6 Cemented Uncemented
7 Cemented Cemented
8 Cemented Uncemented (44), cemented (22)
9 Cemented Uncemented (12), cemented (3)
10 NR NR
11 Cemented Cemented
12 Cemented Uncemented
13 Cemented Varied
14 Cemented Uncemented
15 Cemented Uncemented + plating
16 Cemented Uncemented (13), cemented (2), + plating
Table 4:Tableshowingcomplicationsofprosthesisintoallografttoformtheallograftprosthesiscomposite(APC)andmethodsforsecuring
APCtodistalhostfemur.Thetotalcohortincluded498patientswithameanfollowupof8.1years(range2to16.2years).Thepooledsuccess
rate was 81% (95% CI 77%–86%). Success rate: APC not revised. NR: not reported. Study numbers correlate with Table 1.
Study n Failed constructs Success rate Infection Dislocation Aseptic loosening or fracture
1 30 3 90% 1 (3.3%) 5 (16.7%) 4 (13.3%)
2 21 2 82% 0 0 6 (28.6%)
3 55 6 85% 2 (3.6%) 4 (7.3%) 5 (9.1%)
4 14 4 78% 3 (21.4%) NR 1 (7.1%)
5 15 3 73% 1 (6.7%) 6 (40%) 2 (13.3%)
6 50 8 84% 2 (4%) 4 (8%) 7 (14.0%)
7 44 4 91% 1 (2.3%) 6 (13.6%) 3 (6.8%)
8 72 19 66% 5 (6.9%) 8 (11.1) 14 Loosening (4), resorption (3), nonunion (2),
fracture (4), stem fracture (1)
9 15 2 87% 1 (6.7%) 1 (6.7%) 1 (6.7%)
10 73 13 82% 8 (10.9%) 0 11 (15.1%)
11 32 9 72% 4 (12.5%) NR 5 (15.6%)
12 22 2 91% 1 (4.5%) NR 1 (4.6%)
13 20 1 95% 1 (5.0%) 2 (10%) 0
14 25 2 92% 1 (4.0%) NR 2 (8.0%)
15 37 10 73% 3 (8.1%) NR 7 (18.9%)
16 15 5 67% 3 (20%) 1 (6.7) 4 (20.7%)
junctionasakeyfactorinachievingstabilityofthecomposite
graft, and thereby lowering the chance of mechanical failure
[17, 19, 21, 33].
Cement ﬁxation of the prosthesis to the allograft with
cementless ﬁxation to the host femur was used in seven
studies (see Table 3)[ 6, 19, 24, 25, 27–29]. The rationale
for cement ﬁxation in the allograft-prosthesis composite is
that in-growth and on-growth would not be expected at
the allograft prosthesis interface. Only Zmolek and Dorr
reported a fully uncemented ﬁxation of the prosthesis and
allograftin11patientswithsimilarratesofsuccesscompared
to other studies [18].
Regarding distal ﬁxation to the host femur, an unce-
mented technique was principally employed in nine studies
[6, 18, 19, 22, 24, 25, 27–29], cemented in four studies
[13, 16, 17, 20], mixed cemented and uncemented distal
ﬁ x a t i o ni no n es t u d y[ 21], and one study did not report
w h e t h e ro rc e m e n tw a su s e d( s e eT a b l e3).6 Advances in Orthopedics
For the studies that utilized cementless distal ﬁxation,
some employed a press-ﬁt or interference technique whereas
others used an oblique or step-cut junctional osteotomy.
Saﬁr et al. used an uncemented technique in the distal
host femur with a step-cut or oblique osteotomy aﬀording
direct loading at the allograft-host femur junction [19]. The
authors support the concept that direct loading of the host-
allograft junction minimizes allograft resorption. The distal
femur being initially reamed to the optimal size, with the
proximal femoral allograft also reamed and broached until
a good ﬁt was achieved for the long-stem femoral prosthesis.
The mismatch in the medullary sizes of the host bone and
the allograft resulted in a good press-ﬁt ﬁxation never being
achieved between the femoral stem and the distal host femur.
Further,theallograftwasneveroverreamedtoaccommodate
a larger femoral component for the host femur. In contrast,
Haddad et al. cemented the prosthesis to the distal femur
thus stress shielding, the allograft and commented that this
may explain the high rate of graft resorption (17%) observed
[17].
Overall, cemented ﬁxation in the distal host bone was
associated with a higher rate of aseptic loosening or fracture
(13.7%) when compared to uncemented distal ﬁxation
(9.1%; see Table 4). Whilst the diﬀerence was not statistically
signiﬁcant, the beneﬁt of uncemented distal ﬁxation is the
reduced risk of junctional nonunion between the host femur
and allograft.
The population cohorts, the duration, and complexity
of the surgery result in infection rates for APC being
greater than that for primary hip arthroplasty (see Table 4).
Considering these factors, the pooled 8% infection rate is
not unacceptable. The infection rate is; however, related to
quantity performed with the lowest infection rates (0 to 4%)
being reported in those studies with the greater number of
cases [6, 16, 17, 20]. Although observer bias may inﬂuence
this data, a greater caseload and experience is likely to be
beneﬁcial.
The use of native proximal femur with its soft-tissue
a t t a c h m e n t sa sa no n l a yg r a f ta r o u n dt h ec o m p o s i t ea l l o g r a f t
wasreported in ﬁve studies [19–21,27,29].Thisvascularised
viable bone can promote in-growth into the allograft and
preserves the abductor mechanism and short external rota-
tors. These ﬁve studies report a lower mean dislocation rate
of 9.8%, compared to 14.9% (see Table 4). From the surgical
approaches detailed in these studies, the risk of dislocation
may be minimized by:
(1) preservation of the host posterior capsular structures
if possible,
(2) goodbiomechanicalreconstructionoflength,version
and oﬀset of the prosthesis-allograft construct,
(3) maintaining the bone-soft tissue attachment to the
host femur, to provide both mechanical stability and
to act as a vascularised graft.
Aconstrainedacetabularlinermaybeconsideredincases
of minimal abductor musculature.
5. Conclusion
The continued followup and analysis of this technique
should be encouraged to reﬁne and develop the manage-
ment of massive proximal femoral bone loss. This review
demonstrates that proximal femoral allografts for revision
hip arthroplasty in femoral segmental bone loss do provide
a durable solution, with current available evidence reporting
a survivorship of 80%. Whilst a range of surgical techniques
have been described, this study highlights the following:
(1) highcaseloadisassociatedwithalowerinfectionrate,
(2) uncemented distal ﬁxation is associated with a re-
duced the risk of aseptic loosening or fracture,
(3) if available, using the host femur as an onlay graft
enhances hip stability whilst acting as a vascularised
graft.
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